Researchers develop a mathematical means of assessing COVID-

Researchers develop a mathematical means of assessing COVID-19 tests' false-negative rate
Even with more than 1.5 million Americans receiving a COVID vaccine each day, officials estimate it will take many more months before enough people are protected from the deadly virus. Until then, and potentially beyond, experts agree that opening up schools, restaurants and other public places as safely as possible will rely on widespread testing for SARS-CoV-2, the virus that causes COVID-19.
As of June 2020, the U.S. Food and Drug Administration (FDA) had granted emergency use authorization for more than 85 different viral DNA test kits -- or assays -- each with widely varying degrees of sensitivity and unknown rates of accuracy. However, with no existing gold standard test for the novel coronavirus, there's little data on which to judge these various tests' usefulness to municipalities' efforts to safely re-open for business.

Related Keywords

United States , Americans , Ramy Arnaout , Jamese Kirby , Emily Henderson , Beth Israel Deaconess Medical Center , Beth Israel Lahey Health , Drug Administration , Clinical Infectious , Clinical Microbiology Laboratories , Associate Director , Assay , Corona Virus , Dna , Hospital , Infectious Diseases , Microbiology , Research , Sars , Sars Cov 2 , Vaccine , Virus , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கர்கள் , எமிலி ஹென்டர்சன் , பெத் இஸ்ரேல் டேப்ககோணேஸ் மருத்துவ மையம் , பெத் இஸ்ரேல் லாஹ்ெய் ஆரோக்கியம் , மருத்துவ தொற்று , மருத்துவ நுண்ணுயிரியல் ஆய்வகங்கள் , இணை இயக்குனர் , மதிப்பீடு , கொரோனா வைரஸ் , டீயெநே , மருத்துவமனை , தொற்று நோய்கள் , நுண்ணுயிரியல் , ஆராய்ச்சி , சர்ச் , தடுப்பூசி , வைரஸ் ,